Homeopathic Teething Tablets Recalled Due to Mislabeling

APRIL 17, 2017
Jennifer Barrett, Assistant Editor

Standard Homeopathic Company has issued a nationwide recall of its Hyland’s Baby Teething Tablets and Hyland’s Baby Nighttime Teething Tablets. According to an FDA press release, confirmed amounts of belladonna alkaloids inconsistent with the product’s labeling were found in the products.
 
FDA officials previously issued an announcement urging consumers to avoid these products due to excessive amounts of belladonna found during a laboratory analysis. The company halted production and distribution of the products in October 2016.
 
The company’s products have been sold in retail stores to the consumer level and were used to provide temporary relief of teething symptoms in children. The recall covers all lots of the product that retailers may have in stock.
 
The FDA stated that “there is no known safe dose or toxic dose of belladonna in children because of the many factors that affect it.”
 
No other Standard Homeopathic Company/Hyland’s products are affected by this recall. The FDA urges health care providers and consumers to report any adverse reactions or quality problems experienced with the use of these products.
 
Reference
 
Standard Homeopathic Company issues nationwide recall of Hyland’s Baby Teething tablets and Hyland’s Baby Nighttime Teething tablets due to mislabeling [news release]. FDA’s website. https://www.fda.gov/Safety/Recalls/ucm552934.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery#recall-photos. Accessed April 17, 2017.
 
 
 

SHARE THIS SHARE THIS
81
Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.